Acura Gains as Pfizer Says Pill Reaches Market: Chicago Mover
This article is for subscribers only.
Acura Pharmaceuticals Inc., a maker of technology to deter drug abuse, rose after its short-acting painkiller marketed by Pfizer Inc. became commercially available.
Acura gained 8.1 percent to $4.02 at 4 p.m. in New York. The shares have gained 33 percent in the last 12 months.